Grow in learning
Release time:
2020-08-14
Growing up in Learning
■ Pharmaceutical Sales Company Wang Mei
More than 20 years ago, by chance, I became a member of Jianfeng Group. It was the first year after the listing of the peak stock, just like a handsome man with a successful career and elegant demeanor. However, I was one of the many resettlement employees of the first bankrupt MSG factory in Jinhua City, which was merged by the peak, like a Cinderella with nothing. When I was close to him, I felt a little nervous-I didn't know his temper, for I was afraid that he could not accommodate me, and I was afraid that he would discriminate against me... However, once I really walked into the peak, I found that my worries were unnecessary. As soon as
was merged into the peak, the group company gave us a big lesson to all the placement employees, let us understand the development process, development strategy and objectives of the peak, introduce the corporate culture and employment policy, and carry out reasonable and accurate diversion and placement according to each person's strengths and advantages. Because of my skillful computer typing skills, I successfully applied to work in the printing room of general manager office of the group company. I was not discriminated against or excluded because of the identity of the employees of the original bankrupt enterprise. I also put down the original worries, devoted myself to the new job, and really integrated into the big family of peak.
Within a few years, with the popularization of computer technology and applications, the role of typing and printing work became smaller and smaller. In response to the company's call to streamline the organization, I applied to Jianfeng Pharmaceutical Sales Company for another new job transfer. The original work of the printing office was only step by step, and the leaders did what they said and did, pure and single. However, in pharmaceutical sales companies, it is completely different. Faced with many products, various customers and various sales policies, we must learn everything from scratch. Take answering the phone as an example. At first, I thought that I didn't understand the business. It was always easy to answer the phone, right? But I didn't expect that such a "simple" thing would overwhelm me. In the past, most of the work calls received from familiar colleagues and leaders, and there is no need to pay attention to telephone etiquette and standard Mandarin. However, the sales company is facing customers and consumers all over the country. First of all, you have to say in standard Mandarin at the first time when you pick up the phone: "Hello! Jianfeng Pharmaceutical Sales Company." Show the quality of the spikes. Secondly, we must have a wealth of product knowledge, otherwise we will not only delay the customer's time, but also affect the image of the enterprise. There is also enough patience, especially when encountering consultation calls from foreign patients who do not speak Mandarin, you should listen carefully, ask in detail, and explain patiently. In this way, I learned from small things, with the guidance of leaders and the help of colleagues, I quickly mastered the skills needed for the new position, and gradually grew into a business supervisor who can be independent.
In recent years, with the continuous control of the pharmaceutical industry by the state, various sales policies have appeared frequently, which has brought new pressure and challenges to the employees of our sales company. In the past few years, I have been studying various new policies and regulations, learning new office software, and making suggestions for straightening out the new sales process and improving office efficiency. At the end of last year, in response to the company's request of "three reductions and three improvements", I took over the daily management of the office in addition to the work I was responsible. Grass-roots office work is trivial and complicated, such as salary, entry and departure of employees, signing of labor contracts, examination of various expenses of salesmen, meeting arrangements, transmission of various documents and notices, file management, organization of female workers and trade union activities, etc., which are countless. Many things have never been touched before, and they still have to learn from scratch again. In addition to the existing business work, we can only make use of all available space, arrange the time as a whole, and do our best to do all the work well.
In this continuous learning and progress, unconsciously, I and the peak has been hand in hand for more than 20 years. This is also the best age in my life. I have dedicated my youth, enthusiasm and wisdom to it, and I have no regrets about it. It has been 60 years since Jianfeng founded Jinhua's first cement plant from scratch to become a cross-industry and cross-regional listed company, which embodies the painstaking efforts and sweat of countless ordinary Jianfeng people like me. On the road in the future, I will, as always, follow and dedicate my meager strength to create a "century peak.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31